As expected, Rachel Sherman has become FDA's deputy commissioner for medical products and tobacco, the position Commissioner Robert Califf held prior to his promotion.
A long-time FDA veteran, who left the agency briefly in 2014 before returning once again, Sherman now becomes the overseer of the Centers for Drug And Biologics Evaluation and Research, the Center
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?